Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Home
Tags
Antibody-drug Conjugates
Tag: Antibody-drug Conjugates
Seattle Genetics Rebrands itself as Seagen
Editorial Team
-
October 8, 2020
NBE-Therapeutics Signs Agreement with Exelixis to Advance ADCs Against Multiple Targets
Editorial Team
-
September 9, 2020
New Therapies may Offer Hope for Patients with Metastatic Breast Cancer
Peter Hofland, Ph.D
-
June 24, 2020
Trastuzumab deruxtecan Launched in Japan for HER2+ Unresectable or Metastatic Breast...
Editorial Team
-
May 25, 2020
RemeGen Initiates Clinical Trial for Distamab vedotin, a Novel anti-HER2 Antibody-drug...
Peter Hofland, Ph.D
-
May 1, 2020
STRO-002 Shows Encouraging Results in Phase I Trial in Treatment of...
Peter Hofland, Ph.D
-
April 27, 2020
Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer
Peter Hofland, Ph.D
-
February 19, 2020
Trastuzumab deruxtecan Approved for the Treatment of Metastatic HER2-positive Breast Cancer
Peter Hofland, Ph.D
-
December 21, 2019
FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...
Andrea Maddox-Smith
-
December 20, 2019
FDA Approves New Drug for Advanced Bladder Cancer
Peter Hofland, Ph.D
-
December 19, 2019
1
2
3
4
Page 1 of 4
LATEST NEWS
AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses
Peter Hofland, Ph.D
-
April 13, 2021
A Spaceship on Mars and Screening for Gynecologic Cancer
Valena Wrtight, MD
-
April 6, 2021
Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?
Michael C. Dugan, M.D.
-
April 1, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
Ofer Sharon, MD, MBA
-
March 22, 2021